Project: Part 3 Annotated Bibliography HELP
W3 Issue Review 4
W3 Issue Review
Taylor Wester
Chamberlain University
PHIL 347N
July 19, 2021
W3 Issue Review
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018). Gene therapy clinical trials worldwide to 2017: An update. The journal of gene medicine, 20(5), e3015.Retrieved on 17th July 2021 from https://doi.org/10.1002/jgm.3015
This article discusses the concept of gene therapy and how it is being used in the modern medical environment. Ginn et al. (2018) assert that Gene therapy has in the recent years evolved with a huge success in genetic medicine, laying a key cornerstone for the development of medical technologies. Also, it outlines how over 2600 gene therapy clinical trials have proven important in disease control and treatments. They also discuss the progress gene therapy is causing and advancements in genome editing.The articles covers the first aspect of the critical reasoning paper.
Gabriel, W. (2017). The CRISPR-Cas9 mediated disruption in the ethics of gene therapy: an analysis of contemporary developments. Retrieved on 17th July 2021 from https://digitalwindow.vassar.edu/cgi/viewcontent.cgi?referer=https://scholar.google.com/&httpsredir=1&article=1727&context=senior_capstone
This article discusses the contextualization of gene therapy and how it has redefined the process of understanding the course of humanity from birth to death. The author discusses different concepts involved in the use of gene therapy and whether the new normal should be embraced. Gabriel asserts that indeed gene therapy is the new normal and the future for medical innovations. It is legal and we should embrace it.
Bilkey, G. A., Burns, B. L., Coles, E. P., Bowman, F. L., Beilby, J. P., Pachter, N. S., … & Weeramanthri, T. S. (2019). Genomic testing for human health and disease across the life cycle: applications and ethical, legal, and social challenges. Frontiers in public health, 7, 40.Retrieved on 17th July 2021 from https://doi.org/10.3389/fpubh.2019.00040
This article discusses the ethical, legal and social challenges that genome therapy and testing faces from early human life to the elderly and aged within the society. The article discusses the application of gene therapy and testing within the healthcare spectrum while identifying challenges at each stage and phase of life. Some of the challenges include the definition of terms used in genomic testing, and how data and information on gene testing are protected and shared. The article covers the third aspect of the critical reasoning paper.
References
Bilkey, G. A., Burns, B. L., Coles, E. P., Bowman, F. L., Beilby, J. P., Pachter, N. S., … & Weeramanthri, T. S. (2019). Genomic testing for human health and disease across the life cycle: applications and ethical, legal, and social challenges. Frontiers in public health, 7, 40.Retrieved on 17th July 2021 from https://doi.org/10.3389/fpubh.2019.00040
Gabriel, W. (2017). The CRISPR-Cas9 mediated disruption in the ethics of gene therapy: an analysis of contemporary developments. Retrieved on 17th July 2021 from https://digitalwindow.vassar.edu/cgi/viewcontent.cgi?referer=https://scholar.google.com/&httpsredir=1&article=1727&context=senior_capstone
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018). Gene therapy clinical trials worldwide to 2017: An update. The journal of gene medicine, 20(5), e3015.Retrieved on 17th July 2021 from https://doi.org/10.1002/jgm.3015
Needs help with similar assignment?
We are available 24x7 to deliver the best services and assignment ready within 3-4 hours? Order a custom-written, plagiarism-free paper
Get Answer Over WhatsApp Order Paper Now